We investigated the role of prophylactic lymph node dissection (LND) in patients with intrahepatic cholangiocarcinoma (ICC).
Introduction
Although intrahepatic cholangiocarcinoma (ICC) is a relatively rare tumor, accounting for 10-15% of all primary liver cancer [1, 2] , the incidence of this disease has steadily increased in both Japan and throughout the world [3] [4] [5] . The prognosis of ICC is dismal, with an estimated median survival of only 18-19 months and an estimated 5-year survival rate between 25-40% [6-8] . Curative hepatic resection is the only effective treatment for ICC. Meanwhile, the role of lymph node dissection (LND) is still unclear, despite lymph node metastasis (LNM) having been reported to be a significant risk factor for poor outcome [9] [10] [11] . Some institutions advocate the routine performance of LND for ICC [12] . On the other hand, other institutions consider selective LND and limited application of LND to be reasonable because the prognosis of patients with LNM is poor even if systematic LND is performed [13, 14] . The efficacy of LND is still controversial regarding both treatment for ICC patients with LNM, and prophylactic treatment for ICC patients without LNM. It is desirable for routine and systematic LND to be avoided if possible, especially in the case of prophylactic LND performed in patients without LNM, because performance of LND has been shown to cause increased operative morbidity compared with patients who do not undergo LND [15, 16] . Another problem is that preoperative imaging assessment of LNM is quite difficult [17] [18] [19] , although LNM is considered to be the most important prognostic factor for survival of patients with ICC [9-11]. Accurate preoperative determination of LNM status is important, considered that routine systematic LND could possibly be omitted in patients without LNM. Therefore, the purposes of the present study were to investigate the efficacy of prophylactic LND in ICC patients without LNM, and to evaluate which clinicopathological factors might be associated with the accurate determination of LNM status.
Patients and Methods

Patients
We retrospectively analyzed 64 patients with ICC who underwent resection in our institution from January 1995 to December 2013. ICC was defined as adenocarcinoma arising from the second 2 or greater peripheral branches of the intrahepatic bile ducts. Patients with combined hepatocellular carcinoma and cholangiocarcinoma were excluded from this study. Six patients underwent only laparotomy due to peritoneal dissemination, 2 patients were revealed to have paraaortic lymph node metastasis, and 2 patients were not considered to have undergone radical surgery because of positive surgical margins by pathological examination. Five patients were lost to follow-up. Therefore, the 49 remaining patients who underwent curative resection were enrolled in the present study. Of the 49 patients who underwent curative resection, 38 patients underwent LND, and 11 did not [LND(-) group]. Of the 38 patients who underwent LND, 28 patients did not show histological LNM [LND(+)-LNM(-) group], and 10 patients had histological LNM [LND(+)-LNM(+)]. To evaluate the efficacy of prophylactic LND in ICC patients, we compared the disease-free survival (DFS) and overall survival (OS) rates between the LND(-) group and the LND(+)-LNM(-) group. The study protocol was approved by the Clinical Research Echics Committee of our hospital. Written informed consent which permit was obtained from all patients in the study.
Preoperative diagnosis
Preoperative computed tomography (CT) was performed to evaluate the location, size, and number of the tumors. In cases of lymph nodes measuring >5 mm in diameter on CT, we considered the possibility of LNM and determined LND should be performed. Meanwhile, when LN size was <5 mm on preoperative CT, the decision to perform LND was left to the surgeon's discretion.
Surgical technique
Patients were excluded from surgical resection in cases of peritoneal carcinomatosis or extrahepatic metastasis confirmed at frozen section during surgery. Routine bile duct resection was not performed with LND. LND of the regional LNs was classified according to the Japanese Society of Biliary Surgery (JSBS) classification [20] . We harvested the LNs of the hepatoduodenal ligament (12h, 12a, 12p, 12b), the proper artery (8), and the posterior surface of the pancreatic head (13) during the surgery. In cases of tumor located in the left lobe, we performed sampling dissection of the LNs of the left gastric artery (7), and the LNs along the lesser curvature of the stomach, and around the cardia in addition to the above-mentioned regional LND. The presence of LNM was not regarded as a contraindication to surgical resection.
Statistics
Continuous data were expressed as mean ± SD and were compared using the Mann-Whitney U test. Categorical data were assessed using the chi-squared test. Patient survival and recurrence rates were estimated by the Kaplan-Meier method, and differences between survival curves were tested by the log-rank test. Multivariate analysis was performed according to the Cox proportional hazards model. Statistical analysis was carried out using JMP software (version 9.0; SAS Institute, Inc., Cary, NC, USA).
Results
Patient characteristics in the LND(-)and LND(+)-LNM(-) groups
The demographics and clinicopathological characteristics for patients in the LND(-)and LND(+)-LNM(-) groups are displayed in Table 1 . There were no significant differences in age, gender, value of indocyanine green retention at 15 minutes (ICG15), serum CA19-9 level, tumor number, proportion of tumor locations, histological tumor differentiation grade, vascular invasion, or pTNM stage between the two groups, while tumor size was significantly larger, and the percentage of patients with LN swelling >5 mm on preoperative CT was higher in the LND(+)-LNM(-) group than in the LND(-) group.
Analysis of OS and DFS in the LND(-)and LND(+)-LNM(-) groups
The 1-, 3-and 5-year OS rates were 100.0, 80.0, and 64.6%, respectively, in the LND(-) group, and 88.6, 58.1, and 45.8%, respectively, in the LND(+)-LNM(-) group. There was no significant difference in OS rates between the two groups (p = 0.353) ( Figure 1) . The 1-, 3-and 5-year DFS rates were 63.6, 50.9, and 33.9%, respectively, in the LND(-) group, and 54.6, 45.3, and 45.3% respectively, in the LND(+)-LNM(-) group. There was also no significant difference in DFS rates between the two groups (p = 0.863) ( Figure 1 ).
Sites of initial recurrence
In the LND(-) group, recurrence occurred in 6 of 11 patients; in the LND(+)-LNM(-) group, recurrence occurred in 14 of 28 patients ( Table 2) . Although no local LN recurrence occurred in the LND(-) group, local LN recurrence was seen in 2 patients of the LND(+)-LNM(-) group. The most frequent recurrence site was the liver in both groups.
Uni-and multi-variate risk factor analysis for histological lymph node metastasis
Of the 38 patients who underwent LND, 10 patients had histological LNM. To identify risk factors for histological LNM, we performed uni-and multivariate analysis on preoperative data from the patients who underwent LND (n = 38). Univariate analysis revealed that serum CA19-9 levels >150 U/mL, which was a cut-off value calculated by receiver operating characteristic (ROC) analysis (p = 0.001), and LN size >5 mm on preoperative CT (p = 0.0005) were the significant risk factors for histological LNM (Table 3 ). Multivariate analysis revealed that serum CA19-9 levels >150 U/mL (p = 0.005) and LN size >5 mm on preoperative CT (p = 0.017) were the significant risk factors for histological LNM (Table 3) .
Association with the incidence of LNM and risk factors for LNM
We evaluated the incidence of histological LNM, dividing the patients into 4 groups by LN size (5 mm) and serum level of CA19-9 (150 U/mL) as preoperative independent risk factors of histological LNM (Table 4 ). It was revealed that none of the patients with LN size <5 mm in preoperative CT and serum CA19-9 level ≤150 U/mL had histological LNM among the ICC patients who underwent LND. Conversely, 78% of the patients with LN size >5 mm on preoperative CT and serum CA19-9 level >150 U/mL showed histological LNM.
Discussion
Although the incidence of LNM in ICC patients is high, reportedly ranging from 36 to 62% [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] , and LNM is a strong predictor of worse long-term outcome after curative-intent resection of ICC, the role of LND is still controversial. Some authors have suggested that LND should be performed in all ICC patients to appropriately determine stage and to guide perioperative management [32] . Meanwhile, other authors have noted that LND was not effective in improving survival rates, and have recommended against routine LND [33, 34] . Furthermore, as for prophylactic LND performed in patients without LNM, the impact on outcome has not been elucidated at all. The present retrospective study compared the OS and DFS rates between the patients who did not undergo LND and the patients who underwent LND but did not have LNM to clarify whether LND should be performed prophylactically in patients without LN involvement. The present study demonstrated that there was no significant difference between these two groups, which suggests that prophylactic LND does not contribute to either OS or DFS. Prophylactic LND seems to prevent local LN recurrence by removal of possible microscopic LNM both around the perihepatic LNs and at frequent sites of recurrence. However, the present study investigated the site of initial recurrence, and revealed that local LN recurrence had occurred even in the patients who underwent regional LND despite the fact that none of the patients who did not undergo LND had local LN recurrence. It has been discovered that intrahepatic recurrence is a common recurrence pattern in both the patients who undergo LND and those who do not undergo LND as previous study reported [35, 36] . Another study found that patients who underwent LND but had no LNM appeared to have slightly worse survival rates than patients who did not undergo LND during the earlier portion of the follow-up period [37] . Similarly, in the current study, the patients who underwent LND but had no LNM seemed to have slightly worse survival rates than the patients who did not undergo LND, although the difference was not statistically significant. There may have been some bias regarding whether LND was performed in the patients with LN size <5 mm on preoperative CT. If prophylactic LND could be omitted in the patients without histological LNM, the problem is that preoperative diagnostic imaging techniques, including CT, MRI, and 18F-fluorodexyglucose positron emission tomography, would have difficulty in accurately detecting histological LNM preoperatively. Therefore, the present study investigated significant preoperative risk factors, not postoperative or histological factors, for histological LNM. The results revealed that LN size >5 mm on preoperative CT and serum CA19-9 level >150 U/mL were significant preoperative predictors of histological LNM. In the patients with LN size <5 mm on preoperative CT and serum CA19-9 level ≤150 U/mL among the patients who underwent LND, no patient had histological LNM. Conversely, in the patients with LN size >5 mm on preoperative CT and serum CA19-9 level >150 U/mL who showed histological LNM, the incidence of histological LNM was 78%. These two factors can be very useful for accurately diagnosing LN status. The present study had several limitations. The study was retrospective in nature, so there may have been some selection bias, especially in patients with LN size <5 mm on preoperative CT, because the performance of LND was left to the surgeon's discretion in such patients. Another possible limitation was quite a small sample size in this study. The small number of patients in some subsets may have resulted in a type error in assessing OS and DFS, so it is difficult to draw definite conclusion about the effect of prophylactic LND.
Conclusion
In conclusion, prophylactic LND did not improve survival significantly after curative-intent surgery for ICC, and did not prevent local recurrence in the present study. Systematic regional LND may be not suitable for patients with LN size <5 mm on preoperative CT and serum CA19-9 level ≤150 U/mL. 
